Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate

Infection and Immunity

Volumn 73, Issue 11, 2005, Pages 7569-7577

  Peng, Daxin ^a   Hong, Wenzhou ^a   Choudhury, Biswa P ^b   Carlson, Russell W ^b   Gu, Xin Xing ^a,c  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; LIPID A; LIVE VACCINE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE ACYLTRANSFERASE;

ANTIBACTERIAL ACTIVITY; ANTIBODY RESPONSE; ARTICLE; ATTENUATION; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOSYNTHESIS; CELL ADHESION; CONTROLLED STUDY; DRUG SYNTHESIS; EPITHELIUM CELL; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LIMULUS LYSATE TEST; LIPOGENESIS; LPXA GENE; MORAXELLA CATARRHALIS; MUTANT; NASOPHARYNX; OUTER MEMBRANE; PATHOGENESIS; PRIORITY JOURNAL; PROTECTION; TOXICITY TESTING; WILD TYPE;

ACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; GENES, BACTERIAL; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; MUTATION; VACCINES, ATTENUATED; VIRULENCE FACTORS;

EID: 27744480259     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.11.7569-7577.2005     Document Type: Article

References (45)

1. Aebi, C., E. R. Lafontaine, L. D. Cope, L. Latimer, S. L. Lumbley, G. H. McCracken, Jr., and E. J. Hansen. 1998. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect. Immun. 66:3113-3119.
2. Ahmed, K., N. Rikitonii, A. Ichinose, and K. Matsumoto. 1991. Possible presence of a capsule in Branhamella catarrhalis. Microbiol. Immunol. 35: 361-366.
3. Albiger, B., L. Johansson, and A. B. Jonsson. 2003. Lipooligosaccharide- deficient Neisseria meningitidis shows altered pilus-associated characteristics. Infect. Immun. 71:155-162.
4. Anderson, M. S., and C. R. Raetz. 1987. Biosynthesis of lipid A precursors in Escherichia coll A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine. J. Biol. Chem. 262:5159-5169.
5. Bandak, S. I., M. R. Turnak, B. S. Allen, L. D. Bolzon, D. A. Preston, S. K. Bouchillon, and D. J. Hoban. 2001. Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries. Eur. J. Clin. Microbiol. Infect. Dis. 20:55-60.
6. Campagnari, A. A., T. F. Ducey, and C. A. Rebmann. 1996. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin. Infect. Immun. 64:3920-3924.
7. Catlin, B. W. 1990. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3:293-320.
8. Devi, S. J., R. Schneerson, W. Egan, W. F. Vann, J. B. Robbins, and J. Shiloach. 1991. Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neissena meningitidis, and Escherichia coli K1 (non-O acetylated). Infect. Immun. 59:732-736.
9. Doyle, W. J. 1989. Animal model of otitis media: other pathogens. Pediatr. Infect. Dis. J. 81(Suppl.):S45-S47.
10. Edebrink, P., P. E. Jansson, M. M. Rahman, G. Widmalm, T. Holome, M. Rahman, and A, Weintraub. 1994. Structural studies of the O-polysaccharide from the lipopolysaccharide ai Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr. Res. 257:269-284.
11. Edwards, K. J., S. Allen, B. W. Gibson, and A. A. Campagnari. 2005. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. J. Bacteriol. 187: 2939-2947.
12. Fomsgaard, J. S., A. Fomsgaard, N. Hoiby, B. Bruun, and C. Galanos. 1991. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect. Immun. 59:3346-3349.
13. Galanos, C., O, Luderitz, and O. Westphal. 1969. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9:245-249.
14. Galloway, S. M., and C. R. Raetz. 1990. A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis. J. Biol. Chem. 265:6394-6402.
15. Gronow, S., and H. Brade. 2001. Upopolysaccharide biosynthesis: which steps do bacteria need to survive? J. Endotoxin Res. 7:3-23.
16. Gu, X. X., J. Chen, S. J. Barekamp, J. B. Robbins, C. M. Tsai, D. J. Lim, and J. Battey. 1998. Synthesis and characterization of lipooligosaccharide- based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect. Immun. 66:1891-1897.
17. Helminen, M. E., I. Maciver, J. L. Latimer, L. D. Cope, G, H. McCracken, Jr., and E. J. Hansen. 1993. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:2003-2010.
18. Hoban, D. J., G. V. Doern, A. C. Fluit, M. Roussel-Delvallez, and R. N. Jones. 2001. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32:S81-S93.
19. Holme, T., M. Rahman, P. E. Jansson, and G. Widmalm. 1999. The lipopolysaccharide of Moraxella catarrhalis: structural relationships and antigenic properties. Eur. J. Biochem. 265:524-529.
20. Hu, W. G., J. Chen, F. M. Collins, and X. X. Gu. 2000. An aerosol challenge mouse model for Moraxella catarrhalis. Vaccine 18:799-804.
21. Hu, W. G., J. Chen, J. C. McMichael, and X. X. Gu. 2001. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis. Infect. Immun. 69:1358-1364.
22. Johnson, A. G., G. Gaines, and M. Landy. 1956. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified Upopolysaccharide. J. Exp. Med. 103:225-246.
23. Karalus, R., and A. Campagnari. 2000. Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect. 2:547-559.
24. Kelly, T. M., S. A. Stachula, C. R. Raetz, and M. S. Anderson. 1993. The firA gene of Escherichia coli encodes UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis. J. Biol. Chem. 268: 19866-19874.
25. Luke, N. R., S. Allen, B. W. Gibson, and A. A. Campagnari. 2003. Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant. Infect. Immun. 71:6426-6434.
26. Masoud, H., M. B. Perry, and J. C. Richards. 1994. Characterization of the Upopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A Upopolysaccharide. Eur. J. Biochem. 220: 209-216.
27. McMichael, J. C. 2000. Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections. Microbes Infect. 2:561-568.
28. Murphy, T. F. 1996. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:267-279.
29. Peng, D., B. P. Choudhury, R. S. Petralia, R. W. Carlson, and X. X. Gu. 2005. Roles of 3-deoxy-D-monno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence. Infect. Immun. 73:4222-4230.
30. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
31. Schnaitman, C. A., and J. D. Klena. 1993. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol. Rev. 57:655-682.
32. Steeghs, L., H. de Cock, E. Evers, B. Zomer, J. Tommassen, and P. van der Ley. 2001. Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant. EMBO J. 20:6937-6945.
33. Steeghs, L., R. den Hartog, A. den Boer, B. Zomer, P. Roholl, and P. van der Ley. 1998. Meningitis bacterium is viable without endotoxin- Nature 392:449-450.
34. Steeghs, L., M. P. Jennings, J. T. Poolman, and P. van der Ley. 1997. Isolation and characterization of the Neisseria meningitidis lpxD-fabZ-lpxA gene cluster involved in lipid A biosynthesis. Gene 190:263-270.
35. Steeghs, L., B. Kuipers, H. J. Hamstra, G. Kersten, L. van Alphen, and P. van der Ley. 1999. Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response. Infect. Immun. 67:4988-4993.
36. St. Geme, J. W. 1997. Bacterial adhesins: determinants of microbial colonization and pathogenicity. Adv. Pediatr. 44:43-72.
37. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
38. Tzeng, Y. L., A. Datta, V. K. Kolli, R. W. Carlson, and D. S. Stephens. 2002. Endotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase. J. Bacteriol. 184:2379-2388.
39. Vaara, M. 1993. Antibiotic-supersusceptible mutants of Eschierichia coli and Salmonella typhimurium. Antimicrob. Agents Chemother. 37:2255-2260.
40. van der Ley, P., and L. Steeghs. 2003. Lessons from an LPS-deficient Neisseria meningitidis mutant. J. Endotoxin Res. 9:124-128.
41. Verduin, C. M., C. Hol, A. Fleer, H. van Dijk, and A. van Belkum. 2002. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Rev. 15:125-144.
42. Weiser, J. N., and N. Pan. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30:767-775.
43. West, N. P., H. Jungnitz, J. T. Fitter, J. D. McArthur, C. A. Guzman, and M. J. Walker. 2000. Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect. Immun. 68:4673-4680.
44. York, W. S., A. G. Darvill, M. McNeil, T. T. Stevenson, and P. Albersheim. 1985. Isolation and characterization of plant cell walls and cell wall components. Methods Enzymol. 118:3-40.
45. k (Ga1α1-4Galβ1-4Glc) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum. Infect. Immun. 68:5261-5268.